Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
阿维鲁单抗联合阿昔替尼对比舒尼替尼治疗晚期肾细胞癌:JAVELIN Renal 101 III期试验的生物标志物分析
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-020-1044-8
Motzer, Robert J; Robbins, Paul B; Powles, Thomas; Albiges, Laurence; Haanen, John B; Larkin, James; Mu, Xinmeng Jasmine; Ching, Keith A; Uemura, Motohide; Pal, Sumanta K; Alekseev, Boris; Gravis, Gwenaelle; Campbell, Matthew T; Penkov, Konstantin; Lee, Jae Lyun; Hariharan, Subramanian; Wang, Xiao; Zhang, Weidong; Wang, Jing; Chudnovsky, Aleksander; di Pietro, Alessandra; Donahue, Amber C; Choueiri, Toni K